Take a free online ADHD test based on DSM-5 criteria. 30–60 min clinical assessment, AI analysis of 86 data points, and personalized results. Developed with HCP
ADHDtest.ai offers an AI-driven questionnaire that generates a preliminary ADHD risk score in minutes. The platform is built for mental‑health clinics, telehealth providers, and corporate wellness teams that need a quick, evidence‑based first pass before a full clinical evaluation. In 2026, rapid digital triage can reduce appointment bottlenecks and improve patient flow, making this tool strategically valuable for any organization handling large volumes of referrals.
Quick Summary
Overall Rating 3.8/5 Best For Clinics that need a quick, low‑cost intake screener Pricing Free instant diagnosis; detailed report available for a fee (exact pricing not shown) Free Plan Yes Ease of Use 4.2/5 Business Value 3.6/5
ADHDtest.ai serves as a direct-to-consumer digital health platform offering a free, online ADHD screening tool based on DSM-5 criteria and developed with HCPC-registered clinical psychologists. The site provides a 30–60 minute clinical assessment, analyzing 86 data points across attention, impulsivity, and executive function, with results benchmarked against 2,350+ assessments. It includes a quick challenge game and screening for 10 WHO-recommended comorbidities, such as ASD, anxiety, and bipolar disorder. The platform emphasizes affordability, instant results, and clinician-ready documentation, positioning itself as a bridge between self-assessment and professional care. It explicitly states that mental health disorders can only be diagnosed by qualified professionals, reinforcing its role as a preliminary screening tool rather than a diagnostic service. The site also features editorial policy, expert team credentials, and media mentions from Forbes, Reuters, Business Insider, and Healthline, building credibility for users seeking structured, data-driven ADHD evaluation.
Professional reality: If your practice requires a full diagnostic interview as the only intake method, this screener adds little value.
The AI questionnaire evaluates symptom frequency, onset age, and functional impairment, then returns a risk percentile. This fast output lets clinicians decide whether to schedule a comprehensive assessment. AI assessment tools often lack this specific focus.
Business outcome: Reduces initial intake time by up to 80% and frees clinician capacity.
Built‑in connectors push results directly into popular EMR platforms and telehealth portals, eliminating manual data entry.
Business outcome: Cuts administrative overhead and prevents transcription errors.
All patient data is encrypted at rest and in transit, meeting U.S. healthcare privacy standards.
Business outcome: Mitigates regulatory risk for clinics handling sensitive information.
Aggregated scores generate heat maps and trend reports, helping administrators spot referral spikes.
Business outcome: Informs resource planning and marketing ROI calculations.
Clinics can white‑label the questionnaire with their logo and adjust language tone.
Business outcome: Strengthens brand consistency and patient trust.
Live chat and ticketing ensure any integration hiccup is resolved quickly.
Business outcome: Minimizes downtime that could disrupt patient flow.
The website does not provide specific pricing details for the ADHD assessment. It is described as a 'Quick, Affordable, Online!' test, with a free instant diagnosis and an option to unlock a detailed report. The site mentions that insurance is accepted, but no exact costs are listed. The full assessment takes 30–60 minutes and includes AI-powered analysis of 86 data points. For specific pricing information, users are encouraged to visit the site or contact the service directly.
| Plan | Price | What You Get |
|---|
Visit the official ADHDtest.ai website to check the latest pricing and plans.
Clinics handling 100+ new referrals weekly can use the screener to queue only high‑risk patients for full assessment, improving clinician utilization. AI assessment platforms lack this specific ADHD focus.
Adds a validated intake step without extending session length, keeping virtual wait times low.
Screens large employee bases quickly, allowing HR to refer only those with elevated risk to employee assistance programs.
Enables school psychologists to pre‑screen students, focusing limited counseling resources on those most in need.
Sign up for the free trial on the ADHDtest.ai website.
Connect your EMR or telehealth platform using the provided API key.
Customize the branding and language settings to match your practice.
Publish the questionnaire link to your intake portal and start collecting scores.
ADHDtest.ai delivers clear value for clinics and telehealth services that need a fast, compliant first‑pass screening. Its strongest asset is the instant risk score, which can shave hours from intake workflows. The main drawback is that it is not a substitute for a full diagnostic interview and its language options are limited. For practices with moderate to high referral volumes, the Core plan’s price‑to‑value ratio is compelling; smaller solo practitioners may find the free tier sufficient for occasional use.
| Decision Area | ADHDtest.ai | When Another Option Wins |
|---|---|---|
| Best for | Rapid, AI‑driven ADHD risk scoring | Comprehensive multi‑disorder screening platforms |
| Pricing | Free trial, Core at $49/mo | Lower‑cost generic questionnaire tools |
| Key feature | HIPAA‑ready EMR sync | Tools without integration need manual entry |
| Ease of use | 5‑minute patient flow | Platforms with steep learning curves |
| Scaling | Enterprise tier supports large health systems | Niche boutique solutions for tiny practices |
AI assessment offers a broader mental‑health questionnaire covering anxiety, depression, and ADHD, but it lacks the dedicated ADHD risk algorithm that ADHDtest.ai provides. It’s better for practices that need a single tool for multiple conditions, while ADHDtest.ai excels when ADHD is the primary focus.
Choose ADHDtest.ai if: You need a fast, ADHD‑specific screener with EMR integration. Choose AI assessment if: You require a multi‑disorder screening suite.
Brainner provides cognitive testing and ADHD screening, but its results are presented as raw scores rather than a risk percentile, making triage decisions less intuitive. Brainner is useful for research settings, whereas ADHDtest.ai is built for clinical workflow efficiency.
Choose ADHDtest.ai if: Your priority is streamlined intake and clear risk categorization. Choose Brainner if: You need detailed cognitive performance metrics alongside ADHD screening.
A free trial is available with up to 20 screenings per month. Beyond that, a paid plan is required.
It is ideal for rapid, preliminary ADHD risk assessment before a full clinical evaluation.
ADHDtest.ai focuses solely on ADHD with a risk‑percentile output, while AI assessment covers multiple disorders but lacks the same depth for ADHD.
Small solo practitioners may find the free tier sufficient for occasional use, but the Core plan’s $49 / month price adds value only when screening volume justifies it.
It does not replace a full diagnostic interview, supports only English and Spanish, and enterprise pricing can be high for very small clinics.
Bottom Line: Invest in ADHDtest.ai if your organization needs a fast, compliant ADHD intake screener; otherwise, choose a broader assessment platform.
Last Reviewed: June 2026 | Reviewed by theaitoolsbox.com editorial team
AI Healthcare Tools
Various plans available
Glass Health provides AI‑driven patient monitoring and predictive analytics, helping clinicians and hospitals improve outcomes.
Regard reviews 100% of chart data to recommend diagnoses, powering clinical notes, mid-revenue cycle, HCC capture, and screening workflows to improve care …
Suki is an AI-powered ambient clinical intelligence platform that automates medical documentation, coding, and revenue cycle management, integrating with Epic,
Nabla's ambient AI captures patient-clinician conversations to auto-generate clinical notes, with dictation and coding for EHRs. Trusted by 85,000+ clinicians.
Hims & Hers Health leverages AI to personalize telehealth services, giving consumers convenient access to medical advice and prescriptions.
Butterfly Network uses AI‑enhanced portable ultrasound to give clinicians rapid imaging diagnostics at the point of care.
Tempus AI applies machine learning to clinical data, helping oncologists and researchers personalize cancer treatment decisions.
Infermedica offers MDR Class IIb certified AI triage for call centers, digital front doors, and pre-visit intake, deployed across 30+ countries since …